Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 6Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Triple Negative Breast Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Tamoxifen 3Mastectomy, Segmental 2Immunohistochemistry 2talimogene laherparepvec 1abemaciclib 1Surgical Procedures, Operative 1Sugars 1Specimen Handling 1Radiotherapy 1Radiation 1Nivolumab 1Naltrexone 1Mass Spectrometry 1Lovastatin 1Ipilimumab 1Infliximab 1Hypericum extract LI 160 1Genotype 1Gels 1Gefitinib 1Fluorescent Antibody Technique 1Flow Cytometry 1Chromatography, Liquid 1Chemotherapy, Adjuvant 1Celecoxib 1CTLA-4 Antigen 1Brachytherapy 1Biopsy, Needle 1Biopsy, Fine-Needle 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Breast Carcinoma In Situ × Mastectomy, Segmental × Clear all
NCT00290654 2017-12-28

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
45 enrolled 11 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00082667 2013-02-25

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
1 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡